NCT00336505View on ClinicalTrials.gov

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)

PHASE3CompletedINTERVENTIONAL
Enrollment

584

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Pneumonia
Interventions
DRUG

Cethromycin

Cethromycin 300 mg once per day (QD) for 7 days, administered orally

DRUG

Clarithromycin

Clarithromycin 250 mg twice per day (BID) for 7 days, administered orally

Trial Locations (3)

60517

CANADA - Advanced Life Sciences, Woodridge

SOUTH AFRICA - Advanced Life Sciences, Woodridge

USA - Advanced Life Sciences, Woodridge

Sponsors
All Listed Sponsors
lead

Advanced Life Sciences, Inc.

INDUSTRY